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Abstract: The synthesis of reference standards and expected in vivo metabolites of the first 
adenosine A3 PET radiotracer [
18F]FE@SUPPY ([
18F]fluoroethyl 4,6-diethyl-5-[(ethyl-
sulfanyl)carbonyl]-2-phenylpyridine-3-carboxylate) was achieved by using a straightforward 
microwave assisted alkylation method, which allowed O/S-chemoselective alkylation of 
the starting material 1 to give each target compound 2–8 in a single step. 
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1. Introduction 
Adenosine plays a pivotal role as a key modulator in the human body and acts through four 
different receptor subtypes: A1 (A1AR), A2A (A2AAR), A2B (A2BAR) and A3 (A3AR) receptors [1]. 
The A3AR is known to be involved in a variety of diseases, such as asthma, neurodegenerative 
disorders, inflammatory diseases and lately also showed to be highly expressed on the surface of 
various tumor cells [2,3]. There exists much information on the distribution of the A1 and A2A 
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receptors because good pharmacological tools—including radioligands—are available. In the case of 
A3 receptors, these tools were not yet available, and thus, there were still many open questions 
regarding the distribution and involvement in pathophysiological processes. The fluoroethylester 
FE@SUPPY (5-(2-fluoroethyl)2,4-diethyl-3-(ethylsulfanyl-carbonyl)-6-phenylpyridine-5-carboxylate), 
which was evaluated by Li et al [4], displays high affinity as well as high selectivity for the A3AR. 
These excellent features attested FE@SUPPY as an outstanding ligand for the A3AR. Based on this 
preliminary work, we recently introduced the first potential PET (positron emission tomography)   
tracer [
18F]FE@SUPPY for the A3AR (Figure 1) [5].  
Figure 1. [
18F]FE@SUPPY. 
 
PET excels as a suitable technique for the collection of the lacking data in the living organism and 
at the same time enables direct receptor quantification of receptor densities. As a prerequisite for 
successful PET imaging, suitable radioligands with high affinity, high selectivity and low unspecific 
binding are required [6]. For quality control of these radioligands, non-radioactive reference 
compounds needed to be prepared. These reference compounds did not only serve as reference 
standards for the radiometabolites, but were as well employed in preclinical pharmacokinetic 
experiments of the PET radiotracer [
18F]FE@SUPPY [7]. A one-step approach for the preparation of 
the reference substances was sought in order to promptly achieve those derivatives. In this paper we 
present a straightforward, O/S-chemoselective and microwave assisted alkylation method for the 
synthesis of several reference compounds of FE@SUPPY-derived A3AR radiotracers starting from the 
universal precursor SUPPY: 0 (1). 
2. Results and Discussion 
4,6-Diethyl-2-phenyl-5-(sulfanylcarbonyl)pyridine-3-carboxylic acid) (SUPPY:0, 1) was prepared 
according to our previously published method [8].
 Chemoselective alkylation of the carboxylic acid 
moiety of 1 to afford compounds 2–4 was achieved under microwave assisted reaction conditions in 
acetonitrile in 10–15 min at 150 °C (300–350 W). Methyl trifluoromethanesulfonate, ethyl 
trifluoromethanesulfonate, or 2-fluoroethyl trifluoromethanesulfonate, respectively, were used as 
alkylating agents with cesium carbonate as base and an ionic additive to improve the microwave 
heating of the solvent. NMR analysis of the crude product disclosed a mean oxygen/sulfur alkylation 
ratio of 5:1 for the above described method. Alternatively, methylation of 1 to give product 2 was 
accomplished chemoselectively by treatment with diazomethane in toluene/methanol at room 
temperature in 30 min. To obtain the S-alkylated products 5–7, SUPPY:0 (1) was treated with   
either methyl trifluoromethanesulfonate, ethyl trifluoromethanesulfonate, or 2-fluoroethyl 
trifluoromethanesulfonate under microwave assisted reaction conditions 10 min at 150 °C (300–350 W). 
The addition of ten equivalents of sodium iodide and DMF as solvent were discovered to be the crucial Molecules 2014, 19  4078 
 
 
modifications to achieve the chemoselective reaction at the sulfur atom to afford compounds 5–7 with 
a mean sulfur/oxygen alkylation ratio of 4:1 (NMR analysis of the crude product). Interestingly, 
compound 8 could be made accessible in one single step from SUPPY:0 (1) and 2.4 equivalents of  
2-fluoroethyl trifluoromethanesulfonate by increasing microwave power to 600 W (170 °C, 5 min) 
(Scheme 1).  
Scheme 1. One step O/S-chemoselective alkylation of SUPPY:0 (1). 
 
Reagents and Conditions: (i) Cs2CO3, CH3CN, methyl trifluoromethanesulfonate, ethyl trifluoromethanesulfonate, 
or 2-fluoroethyl trifluoromethanesulfonate, 10–15 min, 150 °C, 300 W; (ii) NaI, DMF, methyl 
trifluoromethanesulfonate, ethyl trifluoromethanesulfonate, or 2-fluoroethyl trifluoromethanesulfonate,   
10 min, 100–150 °C, 300 W; (iii): NaI, DMF, 2-fluoroethyl trifluoromethanesulfonate, 5 min, 170 °C, 600 W.  
3. Experimental 
3.1. General Information 
The NMR spectra were recorded with a Bruker DPX 200 spectrometer (200 MHz for 
1H, 50 MHz 
for 
13C) or a Bruker Avance 500 spectrometer (500 MHz for 
1H, 125 MHz for 
13C, 50 MHz for 
15N, 
470 MHz for 
19F) at 297 K using “directly” detecting broadband observe (BBFO) probes. The center of 
the solvent (residual) signal was used as an internal standard which was related to TMS with δ 7.26 
ppm (
1H in CDCl3), δ 2.49 ppm (
1H in DMSO-d6), δ 77.0 ppm (
13C in CDCl3), and δ 39.50 ppm (
13C in 
DMSO-d6), 
19F NMR spectra were referenced via Ξ ratio. Coupling constants (J) are quoted in Hz. The 
following abbreviations were used to show the multiplicities: s: singlet, d: doublet, t: triplet, q: 
quadruplet, dd: doublet of doublet, m: multiplet. Infrared spectra (IR) were recorded on a Perkin Elmer 
FT-IR spectrophotometer (model spectrum 1000). Mass spectra (MS) were recorded on a Shimadzu 
GC/MS-combined GC/MS-Q95050A GC-17A instrument. High resolution mass spectra (HRMS) were 
recorded under electrospray ionization (ESI), using a Finnigan MAT 900 S instrument. High-resolution 
mass spectrometry was carried out on an electrospray ionization mass spectrometer with a micro-TOF 
analyzer. CHN-analysis was performed by the microanalytical laboratory of the University of Vienna. 
Melting points were determined through a Reichert-Kofler hot-stage microscope. Thin-layer chromatography Molecules 2014, 19  4079 
 
 
analyses were performed using precoated silica gel plates (Merck, Darmstadt, Germany). Column 
chromatography was performed with silica gel 60 or RP-18 silica gel, respectively (Merck). 
Microwave experiments were carried out in a Synthos 3000 microwave oven (Anton Paar, SXQ80 
rotor, Graz, Austria) with an internal temperature probe. 
3.2. General Procedure for the Synthesis of Compounds 2–4 
4,6-Diethyl-2-phenyl-5-(sulfanylcarbonyl)pyridine-3-carboxylic acid (0.10 g, 0.32 mmol), Cs2CO3 
(0.22 g, 0.66 mmol) and the according trifluoromethanesulfonate (0.72 mmol) were suspended in 
CH3CN (10 mL). The reaction mixture was heated in the microwave oven to 150 °C at 300 W for  
10 min (3, 4) or 15 min (2), respectively. Then the solvent was removed under reduced pressure and 
the product purified by column chromatography. 
2,4-Diethyl-5-(methoxycarbonyl)-6-phenylpyridine-3-carbothioic S-acid (2). Purification: RP-18 silica 
gel, CH3CN/H2O 9/1. Yield: 30 mg (29%), white crystals, m.p. 161–162 °C; 
1H-NMR (200 MHz, 
CDCl3) δ (ppm): 7.66 (q, 2H, J = 3.9 Hz), 7.45 (t, 3H, J = 3.42 Hz), 3.66 (s, 3H), 3.06 (t, 2H,  
J = 7.46 Hz), 2.92 (m, 2H), 1.40 (t, 3H, J = 7.44 Hz), 1.28 (t, 3H, J = 7.32 Hz); 
13C-NMR (50 MHz, 
CDCl3) δ (ppm): 189.4, 168.6, 160.1, 157.9, 149.2, 139.3, 130.5, 129.2, 128.4, 128.2, 126.5, 52.4, 
29.4, 15.8, 14.1; IR (KBr): v (cm
−1) 3427, 2974, 2940, 2877, 1728, 1559, 1439, 1403; MS: m/z (%): 
328 (M
+, 1.29), 327 (5), 297 (21), 296 (100), 264 (5), 236 (10), 208 (5), 77 (5); HRMS: m/z calculated 
for C18H18NO3S (M
+–SH): 296.1287. Found: 296.1289; CHN: Anal. calculated for C18H19NO3S: C, 
65.63; H, 5.81; N, 4.25. Found: C, 65.37; H, 5.50; N, 4.41. 
5-(Ethoxycarbonyl)-2,4-diethyl-6-phenylpyridine-3-carbothioic S-acid ( 3). Purification: RP-18 silica 
gel, CH3CN/H2O 9/1. Yield: 120 mg (50%), yellow oil; 
1H-NMR (200 MHz, CDCl3): δ (ppm) 7.63 
(m, 2H), 7.44 (m, 3H), 4.14 (q, 2H, J = 7.20 Hz), 3.05 (q, 2H, J = 7.44 Hz), 2.93 (q, 2H, J = 7.44 Hz), 
1.40 (t, 3H, J = 7.32 Hz), 1.29 (t, 3H, J = 7.46 Hz), 1.03 (t, 3H, J = 7.20 Hz); 
13C-NMR (50 MHz, 
CDCl3): δ (ppm) 189.3, 167.9, 160.0, 158.0, 149.5, 139.1, 130.6, 129.2, 128.4, 127.0, 61.8, 29.3, 24.4, 
15.9, 14.3, 13.6; IR (KBr): ν (cm
−1) 3419, 3058, 2971, 2939, 2875, 1724, 1559, 1475, 1458, 1445, 
1403, 1374, 1344, 1282, 1250, 1215, 1170, 1145, 1092, 1077, 1016, 963; MS: m/z (%) 344 (2), 343 
(3), 341 (43), 312 (19), 311 (17), 310 (100), 282 (29), 254 (13), 236 (11), 77 (14); HRMS: m/z 
calculated for C19H21NO3S: 343.1242. Found: 343.1235. 
2,4-Diethyl-5-[(2-fluoroethoxy)carbonyl]-6-phenylpyridine-3-carbothioic S-acid ( 4). Purification:   
RP-18 silica gel, CH3CN. Yield: 113 mg (95%), colorless crystals, m.p. 45–47 °C; 
1H-NMR (300 MHz, 
CDCl3): δ (ppm) 7.64 (m, 2H, Ph H-2/H-6), 7.46 (m, 3H, Ph H-3/H-4/H-5), 4.39/4.29 (m, 2H, FCH2), 
4.34/4.29 (m, 2H, CH2O), 3.05 (q, 2H, J = 7.50 Hz, C-2CH2), 2.93 (q, 2H, J = 7.50 Hz, C-4CH2) 1.40 
(t, 3H, J = 7.50 Hz, C-2CH2CH3), 1.29 (t, 3H, J = 7.50 Hz, C-4CH2CH3); 
13C-NMR (75 MHz, CDCl3): 
δ (ppm) 189.3 (COSH), 167.9 (COO), 160.4 (C-2), 158.3 (C-6), 149.5 (C-4), 139.3 (Ph C-1), 130.6 (C-3), 
129.3 (Ph C-4), 128.5 (Ph C-3/C-5), 128.3 (Ph C-2/ C-6), 126.2 (C-5), 80.5 (d, FCH2, 
1JCF = 172.0 Hz), 
64.5 (d, CH2O 
2JCF = 20.2 Hz), 29.5 (C-2CH2), 24.4 (C-4CH2), 15.9 (C-4CH2CH3), 14.3 (C-2CH2CH3); 
IR (KBr): ν (cm
−1) 3439, 2975, 2938, 2877, 1731, 1556, 1495, 1448, 1403, 1377, 1278, 1250, 1166, 
1144, 1077, 1060, 1033, 960; MS: m/z (%) 362 (1), 361 (3), 359 (31), 329 (21), 328 (100), 312 (14), Molecules 2014, 19  4080 
 
 
254 (15), 236 (12), 77 (20), 47 (48); CHN: Anal. calculated for C19H20FNO3S·0.2 H2O: C, 62.52; H, 
5.63; N, 3.84. Found: C, 62.45; H, 5.44; N, 3.73. 
3.3. Alternative Method for the Synthesis of 2,4-Diethyl-5-(methoxycarbonyl)-6-phenylpyridine-3-
carbothioic S-acid (2) 
To a stirred solution of 4,6-diethyl-2-phenyl-5-(sulfanylcarbonyl)pyridine-3-carboxylic acid (0.20 g,  
0.63 mmol) in toluene/MeOH (9/6), trimethylsilyldiazomethane (0.4 mL, 0.63 mmol) was added 
dropwise until the yellow color of the mixture persisted. Thereafter, the solution was stirred for another 
30 min at room temperature. The solvent was removed by reduced pressure and product 2 purified by 
reversed phase column chromatography (RP-18 silica gel, CH3CN/H2O 9/1). Yield: 141 mg (68%).  
3.4. General Procedure for the Synthesis of Compounds 5‒7  
4,6-Diethyl-2-phenyl-5-(sulfanylcarbonyl)pyridine-3-carboxylic  acid (0.10 g, 0.32 mmol), NaI 
(0.48 g, 3.17 mmol) and the according trifluoromethanesulfonate (0.72 mmol) were dissolved in DMF 
(10 mL). The reaction mixture was heated in the microwave oven at 300 W and 100 °C for 10 min (6, 
7) or 15 min (5), respectively. The solvent was removed under reduced pressure and the crude product 
purified by column chromatography. 
4,6-Diethyl-5-[(methylsulfanyl)carbonyl]-2-phenylpyridine-3-carboxylic acid (5). Purification: silica 
gel 60, petrol ether/EtOAc 8/2. Yield: 52 mg (49%), colorless crystals, m.p. 243–244 °C; 
1H-NMR 
(200 MHz, DMSO-d6) δ (ppm): 13.63 (s, 1H), 7.55 (q, 5H, J = 3.54 Hz), 2.69 (m, 7H), 1.19 (m, 6H); 
13C-NMR (50 MHz, DMSO-d6) δ (ppm): 195.3, 169.3, 157.8, 155.0, 146.4, 139.1, 132.7, 129.0, 128.3, 
127.9, 28.3, 23.8, 15.6, 13.8, 12.4; IR (KBr): v (cm
−1) 3441, 2983, 2938, 2868, 2492, 1921, 1712, 
1667, 1554; MS: m/z (%): 330 (M
+, 0.12), 298 (1), 283 (17), 282 (100), 236 (6), 180 (5), 127 (7), 77 
(10), 47 (10), 45 (6); HRMS: m/z calculated for C18H19NO3S: 329.1086. Found: 329.1076; CHN: Anal. 
calculated for C18H19NO3S: C, 65.63; H, 5.81; N, 4.25. Found: C, 65.64; H, 5.81; N, 4.06. 
4,6-Diethyl-5-[(ethylsulfanyl)carbonyl]-2-phenylpyridine-3-carboxylic acid (6). Purification: silica gel 
60, petrol ether/EtOAc 8/2.Yield: 94 mg (85%), colorless crystals, m.p. 200–202 °C; 
1H-NMR  
(300 MHz, DMSO- d6): δ (ppm) 13.20 (br s, 1H), 7.65 (m, 2H), 7.45 (m, 3H), 3.12 (q, 2H, J = 7.30 Hz), 
2.76 (q, 2H, J = 7.50 Hz), 2.66 (q, 2H, J = 7.50 Hz), 1.32 (t, 3H, J = 7.50 Hz), 1.24 (t, 3H, J = 7.50 Hz), 
1.17 (t, 3H, J = 7.50 Hz); 
13C-NMR (75 MHz, DMSO-d6): δ (ppm) 194.8, 169.2, 155.0, 146.2, 139.1, 
132.6, 132.6, 128.3, 128.2, 127.9, 28.2, 24.2, 23.6, 15.5, 14.4, 13.7; IR (KBr): v (cm
−1) 3443, 2977, 
2491, 1925, 1711, 1661, 1555, 1453, 1413, 1376, 1260, 1184, 1149, 1078; MS: m/z (%) 344 (1), 343 
(1), 327 (1), 326 (4), 283 (18), 282 (100), 236 (5), 180 (5, 126 (7), 91 (7), 77 (11); CHN: Anal. 
calculated for C19H21NO3S: C, 66.45; H, 6.16; N, 4.08. Found: C, 66.18; H, 6.21; N, 3.96. 
4,6-Diethyl-5-{[(2-fluoroethyl)sulfanyl]carbonyl}-2-phenylpyridine-3-carboxylic acid (7). Purification: 
RP-18 silica gel, CH3CN/H2O 9/1. Yield: 30 mg (52%), colorless crystals, m.p. 195–196 °C; 
1H-NMR 
(200 MHz, DMSO-d6): δ (ppm) 13.67 (s, 1H), 7.65 (m, 2H), 7.46 (t, 3H, J = 3.42 Hz), 4.79 (t, 1H,  
J = 5.68 Hz), 4.55 (t, 1H, J = 5.68 Hz), 3.58 (t, 1H, J = 5.68 Hz), 3.46 (t, 1H, J = 5.54 Hz), 2.71 (m, 
4H), 1.20 (m, 6H); 
13C-NMR (50 MHz, DMSO-d6): δ (ppm) 194.2, 169.2, 157.7, 155.2, 146.4, 139.1, Molecules 2014, 19  4081 
 
 
132.4, 129.0, 128.3, 128.0, 81.6 (d, 
1JCF = 166.5 Hz), 29.9 (d, 
2JCF = 20.7 Hz), 28.3, 23.7, 15.6, 13.8; 
IR (KBr): v (cm
−1) 3446, 2974, 2454, 1966, 1708, 1671, 1555, 1412, 1287, 1183; MS: m/z (%) 283  
(16), 282 (100), 77 (29), 69 (14), 59 (20), 45 (15), 43 (20), 41 (16); CHN: Anal. calculated for 
C19H20FNO3S: C, 63.14; H, 5.58; N, 3.88. Found: C, 63.04; H, 5.54; N, 3.73. 
3.5. Synthesis of 2-Fluoroethyl 4,6-Diethyl-5-{[(2-fluoroethyl)sulfanyl]carbonyl}-2-phenylpyridine-3-
carboxylate (8) 
4,6-Diethyl-2-phenyl-5-(sulfanylcarbonyl)pyridine-3-carboxylic  acid (0.073 g, 0.23 mmol), NaI 
(0.348 g, 2.3 mmol) and 2-fluoroethyl trifluoromethanesulfonate (0.11 g, 0.56 mmol) were dissolved in 
DMF (10 mL). The mixture was heated in the microwave oven at 600 W and 170 °C for 5 min. The 
solvent was then removed under reduced pressure and the crude product purified by RP-18 column 
chromatography (CH3CN/H2O 9/1). Yield: 67 mg (72%), orange oil; 
1H-NMR (200 MHz, CDCl3) δ 
(ppm): 7.60 (m, 2H), 7.43 (m, 3H), 4.77 (t, 1H, J = 5.99 Hz), 4.54 (t, 1H, J = 5.94 Hz), 4.42 (m, 1H), 
4.34 (q, 1H, J = 2.48 Hz), 4.18 (d, 2H, J = 5.18 Hz), 3.52 (t, 1H, J = 5.99 Hz), 3.41 (t, 1H,   
J = 5.94 Hz), 2.87 (q, 2H, J= 7.49 Hz), 2.73 (q, 2H, J = 7.53 Hz), 1.34 (t, 3H, J = 7.51 Hz), 1.24 (t, 
3H, J = 7.57 Hz); 
13C-NMR (50 MHz, CDCl3) δ (ppm): 194.3, 168.1, 159.6, 157.5, 148.2, 139.6, 
132.6,  129.0, 128.4, 128.3, 126.0, 81.3 (d, FCH2CH2O, 
1JCF = 170.5 Hz), 80.5 (d, FCH2CH2S,  
1JCF = 170.2 Hz), 64.1 (d, CH2O 
2JCF = 20.3 Hz), 30.0 (d, CH2S 
2JCF = 22.2 Hz), 29.2, 24.2, 15.7, 14.0; 
IR (KBr): v (cm
−1) 3447, 2977, 2879, 1734, 1675, 1558, 1496; MS: m/z (%): 407 (M
+, 0.59), 329 (21), 
328 (100), 282 (6), 254 (6), 236 (5), 47 (6); HRMS: m/z calculated for C21H24O3F2NS: 408.1445. 
Found: 408.1450. 
4. Conclusions  
In this paper, a straightforward and microwave assisted alkylation method for seven different 
compounds 2‒8 was presented, starting from the universal precursor SUPPY:0 (1). O/S chemoselectivity 
could be achieved through variation of the additive and the solvent. Compounds 2–4 could be made 
accessible through the utilization of Cs2CO3, whereas NaI addition proved to be essential for   
S-chemoselective alkylation and therefore, for the preparation of substances 5–7. However, for the 
synthesis of compound 8, NaI and an increase in microwave power provided the required reaction 
conditions to achieve conversion. All compounds 2‒8 were subjected to detailed NMR spectroscopic 
studies. These target structures served as reference standards in preclinical pharmacokinetic 
experiments of SUPPY:0 derived radiotracers.  
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